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Caraway, Carum carvi L. (Apiaceae), is a biennial or annual herb common in Europe, 
West Asia, and Africa [1]. C. carvi essential oil – Carvi aetheroleum is commonly used 
for flavor, fragrances, and pharmaceutical preparations. In traditional medicine, the 
essential oil is used as an antispasmodic, for the spastic gastrointestinal tract, diuretic, 
antimicrobial, and antioxidant, among other uses [2]. 
 In the present study, Pharmacopoeia grade essential oil from commercial sources 
was evaluated for its antibacterial properties and in vivo toxicity. The chemical 
composition of C. carvi essential oil, analyzed by GC/FID and GC/MS, simultaneously, 
revealed carvone (61.1%) and limonene (37%) as the major constituents. The potential in 
vitro antimicrobial activities of the essential oil and the major components carvone, (+)-
limonene and (-)-limonene were evaluated using the broth microdilution assay [3]. 
Escherichia coli NRRL B-3008, Bacillus cereus NRRL B3711, Salmonella typhimurium 
ATCC 13311 and Streptococcus sanguinis ATCC 10556 were used as the test 
microorganisms. Based on the determined values of Minimum Inhibitory Concentrations 
(MIC) for the essential oil and the major constituents, the activities were relatively low 
(>1000 mg/mL). Lethal concentrations (acute toxicity) were determined by the in vivo 
Caenorhabditis elegans test [4] and the value of LC50 <25 mg/mL was obtained. 
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